Boiron SA (EPA: BOI)
France
· Delayed Price · Currency is EUR 26.50
-0.35 (-1.30%)
Dec 20, 2024, 5:35 PM CET
Boiron Revenue
Boiron had revenue of 228.35M EUR in the half year ending June 30, 2024, a decrease of -11.07%. This brings the company's revenue in the last twelve months to 481.71M, down -6.89% year-over-year. In the year 2023, Boiron had annual revenue of 493.25M, down -7.67%.
Revenue (ttm)
481.71M
Revenue Growth
-6.89%
P/S Ratio
0.96
Revenue / Employee
172.78K
Employees
2,810
Market Cap
460.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 493.25M | -40.99M | -7.67% |
| Dec 31, 2022 | 534.24M | 79.04M | 17.36% |
| Dec 31, 2021 | 455.20M | -58.38M | -11.37% |
| Dec 31, 2020 | 513.58M | -43.54M | -7.82% |
| Dec 31, 2019 | 557.13M | -47.09M | -7.79% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.45B |
| EssilorLuxottica Société anonyme | 25.83B |
| Sartorius Stedim Biotech S.A. | 2.74B |
| bioMérieux S.A. | 3.81B |
| Eurofins Scientific SE | 6.72B |
| Ipsen S.A. | 3.44B |
| Virbac SA | 1.34B |
| Ramsay Générale de Santé SA | 5.01B |